Jump Nav

Our Leadership

The board of directors of PhRMA includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. The senior executive team at PhRMA works closely with the board of directors to advance policies that ensure continued investment in biopharmaceutical innovation.

Leadership

Board of Directors

Peter Anastasiou

President, Lundbeck North America
Lundbeck LLC

-

Read More
A picture of Ken Keller

Ken Keller

President and Chief Executive Officer
Daiichi Sankyo, Inc.

-

Read More

Senior Executives

Stephen J. Ubl

Stephen J. Ubl is a senior executive of PhRMA and President and Chief Executive Officer.

-

Read More

Richard Moscicki, M.D.

Chief Medical Officer and Executive Vice President, Science and Regulatory Advocacy

-

Read More

Robert Zirkelbach

Robert Zirkelbach is a senior executive of PhRMA and Executive Vice President, Public Affairs. 

-

Read More

Paul Lines

Paul Aines is a senior executive of PhRMA and the Executive Vice President, Administration and Chief Financial Officer. 

-

Read More

Lori M. Reilly, Esq.

Lori M. Reilly, Esp. is a senior executive of PhRMA and the Executive Vice President, Policy, Research & Membership. 

-

Read More

James C. Stansel

Executive Vice President & General Counsel

-

Read More